Company Filing History:
Years Active: 2022-2024
Title: Betsy Donnelly: Innovator in Pathogen-Inactivated Platelet Compositions
Introduction
Betsy Donnelly is a prominent inventor based in Moraga, CA (US). She has made significant contributions to the field of medical technology, particularly in the development of methods for preparing pathogen-inactivated platelet compositions. With a total of 2 patents to her name, her work has the potential to enhance the safety and efficacy of blood transfusions.
Latest Patents
Donnelly's latest patents focus on innovative kits and methods for preparing pathogen-inactivated platelet compositions. These patents provide essential methods for ensuring the safety of platelet transfusions by inactivating potential pathogens. The processing sets and compositions related to these patents are crucial for advancing medical practices in transfusion medicine.
Career Highlights
Betsy Donnelly is currently associated with Cerus Corporation, a company dedicated to improving blood safety through innovative technologies. Her role at Cerus has allowed her to work on groundbreaking projects that aim to enhance patient outcomes in transfusion therapies.
Collaborations
Throughout her career, Donnelly has collaborated with notable colleagues, including Tovo David and Anna Erickson. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of medical technology.
Conclusion
Betsy Donnelly's contributions to the field of pathogen-inactivated platelet compositions highlight her dedication to improving medical safety and efficacy. Her innovative work continues to pave the way for advancements in transfusion medicine.